334 related articles for article (PubMed ID: 1315357)
1. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
[TBL] [Abstract][Full Text] [Related]
2. [The effect of some drugs on the levels of selected cytokines in experimental septic shock].
Ladny JR; Dzienis H; Dadan J; Polaków J; Venskutonis D; Puchalski Z
Wiad Lek; 1997; 50 Suppl 1 Pt 2():247-51. PubMed ID: 9424882
[TBL] [Abstract][Full Text] [Related]
3. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
[TBL] [Abstract][Full Text] [Related]
4. Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock.
Chatterjee S; Premachandran S; Shukla J; Poduval TB
J Surg Res; 2007 Jun; 140(1):99-108. PubMed ID: 17292408
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge.
Ono S; Ueno C; Seki S; Matsumoto A; Mochizuki H
Surgery; 2003 Jul; 134(1):92-100. PubMed ID: 12874588
[TBL] [Abstract][Full Text] [Related]
6. Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor).
Ayala A; Perrin MM; Kisala JM; Ertel W; Chaudry IH
Circ Shock; 1992 Mar; 36(3):191-9. PubMed ID: 1611704
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antibody (IL-1rab) protection and treatment against lethal endotoxemia in mice.
McNamara MJ; Norton JA; Nauta RJ; Alexander HR
J Surg Res; 1993 Apr; 54(4):316-21. PubMed ID: 8331925
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of interleukin-6 in the development of sepsis. Part II: Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-alpha antibodies in a standardized murine contact burn model.
Pallua N; Low JF; von Heimburg D
Crit Care Med; 2003 May; 31(5):1495-501. PubMed ID: 12771624
[TBL] [Abstract][Full Text] [Related]
9. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin.
Hadjiminas DJ; McMasters KM; Peyton JC; Cheadle WG
J Surg Res; 1994 Jun; 56(6):549-55. PubMed ID: 8015310
[TBL] [Abstract][Full Text] [Related]
10. Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models.
Libert C; Vink A; Coulie P; Brouckaert P; Everaerdt B; Van Snick J; Fiers W
Eur J Immunol; 1992 Oct; 22(10):2625-30. PubMed ID: 1327800
[TBL] [Abstract][Full Text] [Related]
11. The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor.
Brouckaert P; Everaerdt B; Fiers W
Eur J Immunol; 1992 Apr; 22(4):981-6. PubMed ID: 1532365
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models.
Evans GF; Snyder YM; Butler LD; Zuckerman SH
Circ Shock; 1989 Dec; 29(4):279-90. PubMed ID: 2598414
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
[TBL] [Abstract][Full Text] [Related]
14. Endogenous IL-10 protects mice from death during septic peritonitis.
van der Poll T; Marchant A; Buurman WA; Berman L; Keogh CV; Lazarus DD; Nguyen L; Goldman M; Moldawer LL; Lowry SF
J Immunol; 1995 Dec; 155(11):5397-401. PubMed ID: 7594556
[TBL] [Abstract][Full Text] [Related]
15. Effect of tempol, a membrane-permeable radical scavenger, on mesenteric blood flow and organ injury in a murine cecal ligation and puncture model of septic shock.
Yuksel BC; Serdar SE; Tuncel A; Uzum N; Ataoglu O; Atan A; Hengirmen S; Iskit AB; Guc MO
Eur Surg Res; 2009; 43(2):219-27. PubMed ID: 19556798
[TBL] [Abstract][Full Text] [Related]
16. Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis.
Echtenacher B; Männel DN
J Endotoxin Res; 2002; 8(5):365-9. PubMed ID: 12537695
[TBL] [Abstract][Full Text] [Related]
17. Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.
Alexander HR; Sheppard BC; Jensen JC; Langstein HN; Buresh CM; Venzon D; Walker EC; Fraker DL; Stovroff MC; Norton JA
J Clin Invest; 1991 Jul; 88(1):34-9. PubMed ID: 2056127
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of the cholinergic anti-inflammatory pathway against septic shock in rats.
Song XM; Li JG; Wang YL; Hu ZF; Zhou Q; Du ZH; Jia BH
Shock; 2008 Oct; 30(4):468-72. PubMed ID: 18391858
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
